Teva Pharma Industries Ltd ADR (TEVA)

Teva Pharmaceutical Industries Limited, traded as ADR on NYSE under the symbol TEVA, is a global company that develops, manufactures, and distributes generic medicines, specialty medicines, and biopharmaceutical products across North America, Europe, Israel, and internationally.

The company's product range includes a variety of generic medicines in different forms like tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, creams, sterile products, hormones, high-potency drugs, cytotoxic substances, and products that combine medical devices with medications.

Teva Pharma focuses on therapeutic areas such as the central nervous system (CNS), respiratory, and oncology. They supply active pharmaceutical ingredients, offer contract manufacturing services, and have an out-licensing platform that provides a product portfolio to other pharmaceutical companies.

Some of Teva's well-known drugs include BENDEKA, TREANDA, COPAXONE, AJOVY, AUSTEDO, GRANIX, and more. They also market over-the-counter products under leading names like SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA.

Established in 1901 and headquartered in Tel Aviv, Israel, Teva Pharma has collaboration agreements with companies like MedinCell, Sanofi, Alvotech, and Biolojic Design Ltd., along with a license agreement with MODAG GmbH.

For more information, you can visit their website at https://www.tevapharm.com.